Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 19, 2008 08:15 ET | Source: Marshall Edwards, Inc.

Marshall Edwards, Inc. Announces Resignation of Stephen Breckenridge From Board of Directors and Appointment of William Rueckert as Chairman of Audit Committee

NEW CANAAN, CT--(Marketwire - December 19, 2008) - Marshall Edwards, Inc. (NASDAQ: MSHL) announced that Stephen Breckenridge resigned as a member of the Board of Directors effective December 15, 2008...
December 05, 2008 08:00 ET | Source: Bionor Immuno

Norwegian Research Council Names Bionor Immuno "Most Innovative Company of the Year"

OSLO, NORWAY and BETHESDA, MD--(Marketwire - December 5, 2008) - Bionor Immuno officials today accepted the Norwegian Research Council's prestigious "Most Innovative Company of the Year" award. The...
December 01, 2008 08:10 ET | Source: NOVOGEN LIMITED

Novogen's NV-128, a Novel mTOR Inhibitor, Shows Potential Activity Against Cancer Stem Cells

SYDNEY, AUSTRALIA and NEW CANAAN, CT--(Marketwire - December 1, 2008) - Pharmaceutical company Novogen Limited (NASDAQ: NVGN) (ASX: NRT) today announced that work performed in collaboration with a...
December 01, 2008 08:10 ET | Source: Marshall Edwards, Inc.

Marshall Edwards, Inc. Files IND Application for Triphendiol

NEW CANAAN, CT--(Marketwire - December 1, 2008) - Marshall Edwards, Inc. (NASDAQ: MSHL) today announced that it has filed an application with the United States Food and Drug Administration for an...
November 24, 2008 12:59 ET | Source: Biotechnology Industry Organization

Rescinding the Ban on Embryonic Stem Cell Research: Experts Speak Out on What's Next for This Area of Biotechnology

WASHINGTON, DC--(Marketwire - November 24, 2008) - President-Elect Barack Obama has announced that soon after his inauguration, he will lift the ban on federally funding research using additional...
November 13, 2008 08:10 ET | Source: Novogen, Limited

Independent Data Monitoring Committee Recommends Marshall Edwards, Inc.'s OVATURE Trial Continue

NEW CANAAN, CT--(Marketwire - November 13, 2008) - The Independent Data Monitoring Committee (IDMC) constituted to oversee the conduct of the Phase III OVArian TUmor REsponse (OVATURE) Trial,...
November 12, 2008 08:10 ET | Source: Marshall Edwards, Inc.

Independent Data Monitoring Committee Recommends Marshall Edwards, Inc.'s OVATURE Trial Continue

NEW CANAAN, CT--(Marketwire - November 12, 2008) - The Independent Data Monitoring Committee (IDMC) constituted to oversee the conduct of the Phase III OVArian TUmor REsponse (OVATURE) Trial,...
October 30, 2008 19:19 ET | Source: Novogen, Limited

Marshall Edwards' Phenoxodiol and Novogen's NV-128 Display Divergent Mechanisms of Action but Potent Synergistic Anti-Cancer Activity When Used in Combination

NEW CANAAN, CT and SYDNEY, AUSTRALIA--(Marketwire - October 30, 2008) - Pre-clinical studies presented at the 9th International Conference on Membrane Redox Systems in Wellington New Zealand this...
September 11, 2008 16:40 ET | Source: Malaysian Rubber Export Promotion Council

No Shortage of Medical Glove Supply in U.S. Says MREPC

WASHINGTON, DC--(Marketwire - September 11, 2008) - The Malaysian Rubber Export Promotion Council (MREPC), representing the world's largest group of medical glove manufacturers, today announced that...
August 11, 2008 08:15 ET | Source: Marshall Edwards, Inc.

Marshall Edwards, Inc. to Present at the Canaccord Adams 28th Annual Global Growth Conference

NEW CANAAN, CT and SYDNEY, AUSTRALIA--(Marketwire - August 11, 2008) - Marshall Edwards, Inc. (NASDAQ: MSHL) will present at the Canaccord Adams 28th Annual Global Growth Conference on Wednesday 13...